QUOIN PHARMACEUTICALS LTD

Historical 13F Holders

Symbol: QNRX
CUSIP: 74907L409
All holders as of: Q2 2026
Type: Equity
Class: SPONSORED ADS

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74907L409 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Ikarian Capital, LLC 13G/A Amendment 2	4.4%	211,538	13G/A Amendment 2	10/7/2026 Event 9/30/2026
Ikarian Capital, LLC	4.4%	211,538
Neil Shahrestani	4.4%	211,538
Integrated Core Strategies (US) LLC 13G	5.5%	3,850,385	13G	6/2/2026 Event 5/26/2026
Integrated Core Strategies (US) LLC	5.5%	3,850,385
Millennium Management LLC	5.5%	3,850,385
Millennium Group Management LLC	5.5%	3,850,385
Israel A. Englander	5.5%	3,850,385
ADAR1 Capital Management, LLC 13G/A Amendment 1	4.9%	102,883	13G/A Amendment 1	5/15/2026 Event 3/31/2026
ADAR1 Capital Management, LLC	4.9%	102,846
ADAR1 Capital Management GP, LLC	4.9%	102,883
Daniel Schneeberger	4.9%	102,846
Stonepine Capital Management, LLC 13G/A Amendment 2	10.0%	7,594,166	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Stonepine Capital Management, LLC	10.0%	7,594,166
Stonepine Capital, L.P.	10.0%	7,594,166
Stonepine GP, LLC	10.0%	7,594,166
Jon M. Plexico	10.0%	7,594,166
Woodline Partners LP 13G/A Amendment 1	4.4%	2,785,370	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Aberdeen Group plc 13G/A Amendment 1	4.2%	75,000	13G/A Amendment 1	4/29/2026 Event 4/1/2026
Aberdeen Group plc	4.2%	75,000
abrdn Inc.	4.2%	75,000
ADAR1 Capital Management, LLC 13G	6.9%	58,230	13G	2/17/2026 Event 12/31/2025
ADAR1 Capital Management, LLC	6.9%	58,230
ADAR1 Capital Management GP, LLC	6.0%	50,226
Daniel Schneeberger	6.9%	58,230
Woodline Partners LP 13G	9.5%	2,785,370	13G	2/17/2026 Event 12/31/2025
Integrated Core Strategies (US) LLC 13G/A Amendment 1	4.6%	2,618,595	13G/A Amendment 1	2/11/2026 Event 12/31/2025
Integrated Core Strategies (US) LLC	4.6%	2,618,595
Millennium Management LLC	4.6%	2,618,595
Millennium Group Management LLC	4.6%	2,618,595
Israel A. Englander	4.6%	2,618,595
Ikarian Capital, LLC 13G/A Amendment 1	12.6%	211,538	13G/A Amendment 1	2/6/2026 Event 1/31/2026
Ikarian Capital, LLC	12.6%	211,538
Neil Shahrestani	12.6%	211,538
Stonepine Capital Management, LLC 13G/A Amendment 1	10.6%	3,271,100	13G/A Amendment 1	2/2/2026 Event 1/29/2026
Stonepine Capital Management, LLC	10.6%	3,271,100
Stonepine Capital, L.P.	10.6%	3,271,100
Stonepine GP, LLC	10.6%	3,271,100
Jon M. Plexico	10.6%	3,271,100
Aberdeen Group plc 13G	8.9%	75,000	13G	1/28/2026 Event 12/31/2025
Aberdeen Group plc	8.9%	75,000
abrdn Inc.	8.9%	75,000
Stonepine Capital Management, LLC 13G	9.9%	3,030,926	13G	12/16/2025 Event 12/10/2025
Stonepine Capital Management, LLC	9.9%	3,030,926
Stonepine Capital, L.P.	9.9%	3,030,926
Stonepine GP, LLC	9.9%	3,030,926
Jon M. Plexico	9.9%	3,030,926
Ikarian Capital, LLC 13G	25.2%	211,538	13G	12/15/2025 Event 11/30/2025
Ikarian Capital, LLC	25.2%	211,538
Neil Shahrestani	25.2%	211,538
Resolute Capital Asset Partners LLC 13G	8.5% Checked 5% or less	50,000	13G	12/11/2025 Event 10/10/2025
Resolute Capital Asset Partners LLC	8.5%	50,000
Resolute Capital Asset Partners Fund I LP	8.5%	50,000
Integrated Core Strategies (US) LLC 13G	9.0%	1,901,585	13G	10/27/2025 Event 10/20/2025
Integrated Core Strategies (US) LLC	9.0%	1,901,585
Millennium Management LLC	9.0%	1,901,585
Millennium Group Management LLC	9.0%	1,901,585
Israel A. Englander	9.0%	1,901,585
Armistice Capital, LLC 13G/A Amendment 1	4.99%	1,081,183	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Armistice Capital, LLC	4.99%	1,081,183
Steven Boyd	4.99%	1,081,183

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	1	3.12 k	$14.2 k	$0
2026 Q2	19	1.30 M	$6.29 M	$0
2026 Q1	21	1.18 M	$7.82 M	$0
2025 Q4	18	843 k	$12.2 M	$0
2025 Q3	4	1.49 k	$10.7 k	$0
2025 Q2	7	2.54 k	$23.4 k	$0
2025 Q1	1	108	$24.00	$0